CTLA4 and neoplasm: demonstrated that knockout of PKA Cβ in macrophages prevents M2 polarization and that liposomal delivery of PKA inhibitors to tumor-infiltrating macrophages enhances the therapeutic efficacy of anti-CTLA-4 antibodies, effectively counteracting breast cancer tumor growth and metastatic potential in mice (170).